Please login to the form below

Not currently logged in
Email:
Password:

New accounts: December - PR & Med Ed

The following tables list new pharmaceutical account wins notified to us by the winning agencies for the period September to November 2006 inclusive
The following tables list new pharmaceutical account wins notified to us by the winning agencies for the period September to November 2006 inclusive. Please note that inclusion in this table does not necessarily indicate exclusivity and other agencies may also be involved with some of the products listed in other ways, or in domestic, overseas or international markets.

Cephalon

Targretin

Oncology

LeapFrog Medical

Gr˙nenthal

Analgesic product portfolio

Pain

Munro & Forster

Gr˙nenthal

Belara Publication Plan

Gynaecology

Zaicomm MMC

MSD

Univadis website

N/A

LeapFrog Medical

Novo Nordisk

Healthspan range

Vitamins and minerals

Spink Consumer Relations

Oraldent

Gengigel

Oral treatment

Ware Anthony Rust

Pfizer UK

Macugen

Ophthalmology

Zaicom MMC

Pfizer UK

Vfend

Anti-infectives

Zaicom MMC

Quintiles (international)

Phase I trials

Corporate communications

Huntsworth Health

Reckitt Benckiser (global)

Nurofen

Pain

Virgo Health PR

Roche Products UK

Bondronat

Oncology

Just::

Solvay

Creon

Cystic fibrosis

LeapFrog Medical

Takeda Europe

Actos

Type II diabetes

The Remedy, Fleishman-Hillard

Takeda Europe

Blopress

Hypertension

The Remedy, Fleishman-Hillard

Takeda Europe

Prostap SR

Prostate cancer

The Remedy, Fleishman-Hillard

Takeda Europe

Rozerem

Insomnia

The Remedy, Fleishman-Hillard

Takeda Europe

International medical meetings

N/A

The Remedy, Fleishman-Hillard

TCN

Corporate PR

Independent healthcare

Zaicom MMC

2nd September 2008

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Dice Medical Communications

Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop...

Latest intelligence

Peter Jackson
Rethinking our approach to infectious disease preparedness
The importance of long-term strategic investment to prepare for the next threat that emerges...
New from the PhRMA: Diversity in clinical trials principles summarised
In November 2020, PhRMA announced the first-ever, industry-wide principles on clinical trial diversity. The principles were approved by the PhRMA Boards of Directors and will take effect in April 2021....
New from the FDA: Diversity in clinical trials guidance summarised
In November 2020, the FDA released guidance to enable greater diversity in clinical trials through changes to eligibility criteria, enrolment practices, and trial designs....

Infographics